Synapse - Andrew Zelenetz

Search Within

Andrew D Zelenetz

Results (785)

Follicular dendritic cell sarcoma: An underrecognized disease entity with highly heterogeneous clinical, pathologic, and histogenetic characteristics

Meeting Abstract

Bohn, O. L.; Maragulia, J.; Lin, O.; Zelenetz, A. D.; Teruya-Feldstein, J.; Arcila, M. E.
Laboratory Investigation (2013)

Fulltext@MSK | Save

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma

Journal Article

Moskowitz, A. J.; Hamlin, P. A. Jr; Perales, M. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: A single institution experience

Journal Article

Voss, M. H.; Lunning, M. A.; Maragulia, J. C.; Papadopoulos, E. B.; Goldberg, J.; Zelenetz, A. D.; Horwitz, S. M.
Clinical Lymphoma, Myeloma and Leukemia (2013)

Fulltext@MSK | Save

Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies

Journal Article

Vijai, J.; Kirchhoff, T.; Schrader, K. A.; Brown, J.; Dutra Clarke, A. V.; Manschreck, C.; Hansen, N.; Rau-Murthy, R.; Sarrel, K.; Przybylo, J.; more...
PLoS Genetics (2013)

Fulltext@MSK | Save

Examination of the follicular lymphoma international prognostic index (FLIPI) in the national lymphocare study (NLCS): A prospective US patient cohort treated predominantly in community practices

Journal Article

Nooka, A. K.; Nabhan, C.; Zhou, X.; Taylor, M. D.; Byrtek, M.; Miller, T. P.; Friedberg, J. W.; Zelenetz, A. D.; Link, B. K.; Cerhan, J. R.; more...
Annals of Oncology (2013)

Fulltext@MSK | Save

Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)

Meeting Abstract

Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Central nervous system involvement in T-cell lymphomas: A single center experience

Meeting Abstract

Gurion, R.; Maragulia, J.; Zelenetz, A. D.; Horwitz, S. M.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

An enhanced international prognostic index (IPI) for patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era using the National Comprehensive Cancer Network (NCCN) database

Meeting Abstract

Zhou, Z.; Rademaker, A. W.; Gordon, L. I.; LaCasce, A. S.; Vanderplas, A.; Crosby-Thompson, A.; Zelenetz, A. D.; Abel, G. A.; Rodriguez, M. A.; Nademanee, A.; more...
Blood (2012)

Fulltext@MSK | Save

Primary breast diffuse large B cell lymphoma: A distinct clinical entity

Meeting Abstract

Salzberg, M. P.; Maragulia, J. C.; Press, O. W.; Habermann, T. M.; Vose, J. M.; Bast, M.; Advani, R. H.; Evens, A. M.; Islam, N.; Leonard, J. P.; more...
Blood (2012)

Fulltext@MSK | Save

Evaluation of dual tracer (FLT and FDG) PET imaging as part of risk-adapted therapy for patients with advanced stage diffuse large B cell lymphoma (DLBCL)

Meeting Abstract

Moskowitz, C. H.; Schoder, H.; Hamlin, P.; Maragulia, J. C.; Walkley, J.; Zelenetz, A. D.
Blood (2012)

Fulltext@MSK | Save